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    Introduction 
  Fractional skin resurfacing, primarily with erbium 
and carbon dioxide (CO  2  ) lasers, has emerged as 
an effective therapeutic approach with an attractive 
efﬁ  cacy-to-downtime ratio (1  –  4). By limiting energy 
to a grid of small foci within a treatment ﬁ  eld, high 
energies can be delivered, while undamaged skin 
surrounding each focus of ablation provides the basis 
for rapid re-epithelialization. Fractional lasers have 
been applied to the treatment of acne scars and facial 
rhytids with great success (5,6). Plasma technology 
has also been reported to be safe and effective when 
applied in a non-fractional manner for facial rejuve-
nation, albeit with prolonged erythema and a need 
for pain control when used at higher energies (7  –  10). 
More recently, devices have been developed that 
allow the treatment of the face with fractional radio-
frequency (RF), based also on the rationale of placing 
a grid of high-energy foci evenly on the skin. 
  The Pixel RF device (Alma Lasers, Israel) was 
developed as a minimally ablative fractional technology, 
which uses unipolar RF technology to provoke plasma 
sparks, creating multiple controlled micro-perfora-
tions on the skin. The handpieces give rise to a series 
of closely spaced spicules, which contact the skin and 
provide a thin air gap between the skin surface and 
the roof of the electrode (Figure 1). The discharge of 
RF energy at a small distance from the skin forms 
plasma, a gas-like state in which a portion of the 
molecules are ionized. As plasma is very sensitive to 
electromagnetic ﬁ  elds, the RF current triggers micro-
sparks in the plasma between the skin surface and 
the electrode spicules. These sparks cause mild epi-
dermal ablation and perforate the dermis superﬁ  -
cially to form micro-channels. Porcine skin models, 
performed prior to clinical evaluation, demonstrated 
that the depth and diameter of the   ‘  pixels  ’   of injury 
depend on the RF power and pulse duration, and 
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  Abstract 
    Introduction  : Fractional ablative and non-ablative lasers have gained popularity in the treatment of acne scars and rhytids 
due to their efﬁ  cacy and improved tolerability. Plasma and radio frequency (RF) have also emerged as methods for ablative 
or non-ablative energy delivery. We report preliminary experience with a novel fractional micro-plasma RF device for the 
treatment of facial acne scars and rhytids.   Methods  : Sixteen patients with facial acne scars or rhytids were treated at 4-week 
intervals. Treatment parameters were titrated to an immediate end point of moderate erythema. The clinical end point for 
cessation of treatment was the attainment of satisfactory clinical results. Results were monitored photographically up to 3 
months after treatment.   Results  : Acne scars showed marked improvement after two to four treatments. Facial rhytids dem-
onstrated reduced depth after two treatments and marked improvement after four treatments. Treatment was well tolerated 
by all participants, with transient erythema and short downtime. These results provide initial evidence for the safety and 
effectiveness of fractional micro-plasma RF as a low-downtime and well-tolerated modality for the treatment of acne scars 
and facial rhytids.   
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Figure 1.         Pixel RF tips, showing the spicules that form the small foci of contact with the skin, in the roller conﬁ  guration (left) and in 
stationary tips (right).   
    Figure 2.         Histological changes following Pixel RF application to 
porcine skin in preclinical studies. Day 0: wedge-shaped channel 
of tissue ablation formed in the epidermis and papillary dermis 
by a single pulse of 45 watts RF; Day 3: re-epithelialization of 
full-thickness epidermis, except the stratum corneum; Day 14: 
complete healing.   
range from 100 to 150   m  m in depth and from 80 to 
120   m  m in diameter (Figure 2). The technology 
improves upon conventional RF by leveraging the 
generation of plasma to generate focally higher con-
ductivity and thereby triggering micro-sparks and 
high temperatures in minute foci. 
  We report here the initial experience of treating 
facial acne scars and rhytids.     
  Materials and methods 
  All participants signed an informed consent prior 
to treatment. Indications included facial acne scars 
and facial rhytids. Contraindications to treatment 
were Fitzpatrick skin types V  –  VI, active bacterial or 
viral infection, use of isotretinoin within the prior 
12 months, impaired immune function, active col-
lagen vascular disease, malignancy, diabetes, preg-
nancy, a pacemaker or deﬁ  brillator, metal implants 
near the treatment area, and an ablative skin pro-
cedure within the prior 3 months. At one clinical 
site (T.M.), patients who were known to be sus-
ceptible to HSV reactivation received prophylaxis 
with oral antiherpetic medications on the day 
before treatment (acyclovir 400 mg twice daily or 
famciclovir 250 mg twice daily). At the same clin-
ical site, patients felt to be at increased risk for 
hyperpigmentation, based on physician assess-
ment, were pre-treated with hydroquinone starting 
1 month prior to treatment. 
  After pre-treatment with a topical lidocaine gel, 
the Pixel RF device was applied using a 12 mm station-
ary tip or a roller tip (Figure 1). For acne scars, Fitz-
patrick skin types I  –  III were treated with the 12-mm 
stationary tip for ﬁ  ve stacked pulses at 40  –  50 watts, 
0.2 seconds followed by ﬁ  ve passes of the roller tip at 
35  –  50 watts over the entire anatomical facial unit. Fitz-
patrick IV skin was treated with ﬁ  ve to seven passes of 
the roller tip only, at 35  –  50 watts. For facial rhytids, all 
skin types were treated with the 12-mm stationary tip 
for ﬁ  ve stacked pulses at 40  –  50 watts, 0.2 seconds over 
the rhytids, followed by ﬁ  ve to six passes of the roller 
tip at 35  –  50 watts over the affected facial units. 
  Treatments were repeated at intervals of 4  –  6 
week. The clinical end point for cessation of 
treatment was the attainment of satisfactory clinical 
results.     210   S. Halachmi et al.   
   
Figure 3.         Treatment of acne scars. (A) Acne scars before and 1.5 months after three treatments; (B) acne scars before and 3 months after 
three treatments.   
  Results 
  A total of 16 patients were treated (ﬁ   ve male, 11 
female). The clinical endpoint for completion of 
treatment was moderate erythema. Owing to the 
rapid motion of the roller tip over large areas, the ﬁ  ve 
passes over the face were swift and well tolerated. The 
total treatment time for the full-face was approxi-
mately 10 minutes. All facial treatments were well 
tolerated with no adverse events. Mild-to-moderate 
erythema was present for 1 day after treatment. A 
pale pixel-pattern grid was evident for 3 days, over a 
background of ﬁ  ne exfoliative scale. 
  Eight patients with acne scars were treated. The 
mean age was 34.5 years (range 23  –  57). Patients under-
went one to four treatments (mean 3.1). Acneiform 
scars demonstrated cumulative improvement, with 
notable improvement after three treatments (Figure 3A). 
The effect was maintained at 3 months  ’   follow-up 
(Figure 3B). Of interest, patients with mild active acne 
experience a reduction in active acneiform lesions 
during the treatment and follow-up interval. 
  Eight patients underwent treatment for facial 
rhytids. The mean age was 58.8 years (range 51  –  63). 
Patients underwent two to four treatments (mean 2.6). 
Wrinkles were visibly reduced after two treatments, 
with notable improvement in wrinkle appearance and 
visual skin texture after four treatments (Figure 4). 
Longer-term follow-up showed maintained beneﬁ  t at 
3 months, with a more even appearance as well as reduc-
tion in the visual prominence of wrinkles (Figure 5).     
  Discussion 
  In this preliminary assessment, the Pixel RF demon-
strated visible results in the improvement of facial 
acne scars and rhytids after a series of treatments. 
Incremental beneﬁ  t was achieved with repeated treat-
ments, and results were maintained at 3-month 
follow-up evaluations. No severe adverse events were 
reported. 
  Of interest, in several participants, incidental 
beneﬁ  ts were noted outside of the indication being 
treated. In one participant, treatment of acne scars 
resulted in improvement of active acneiform lesions 
within the treatment area, presumably due to dermal 
heating and its effects on sebaceous gland function, 
although the mild exfoliative response to treatment 
within the ﬁ  rst 3 days after the procedure may con-
tribute as well. In another participant, treatment of 
acne scars showed improvement in freckling within 
the treated area. Such a response is compatible with 
epidermal turnover and subsequent rejuvenation as 
a response to the fractional micro-plasma RF, and 
suggests that the procedure may be a good treatment     Fractional micro-plasma RF     211
   
Figure 5.         Treatment of facial rhytids. (A, B) Facial rhytids before and 3 months after three treatments.   
   
Figure 4.         Treatment of facial rhytids. (A) Facial rhytids before and 1 month after two treatments; (B) facial rhytids before and 1 month 
after three treatments; (C) facial rhytids before and 1 month after four treatments.   
option for reversing certain epidermal signs of 
photoaging, in addition to targeting dermal deﬁ  cits. 
This would make the procedure appropriate not only 
for discrete lesions, as was assessed here, but for 
improving the appearance of entire regions. Given 
the rapid coverage with the roller tip, which provides 
treatment of the full face with ﬁ  ve passes in 10 minutes, 
the procedure may be amenable to the treatment of 212   S. Halachmi et al.   
larger areas on the body. This will be investigated in 
future studies. 
  Taken together, the results provide evidence for 
safety and for beneﬁ  cial effects of fractional micro-
plasma RF treatments in visible improvement of 
facial acne scars and rhytids. The Pixel RF adds an 
additional tool to the growing armamentarium of 
fractional therapies. 
    Conﬂ  icts of interest: Dr Orenstein and Dr Lapidoth 
received equipment for use in this work.                   
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